Cardinal Health, Inc. CAH Cash Flow

Cardinal health, inc. (CAH)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Sep'09	Jun'09	Mar'09	Dec'08	Sep'08
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
-4,155	-4,210	-4,150	1,365	4	-37	736	259	1,703	1,830	1,101	1,294	1,351	1,355	1,357	1,431	1,391	1,370	1,333	1,215	1,154	1,104	1,093	1,166	346	376	402	334	1,157	1,145	1,103	1,069	1,034	947	901	959	979	955	975	642	691	782	864	1,151	0	0	0
Earnings from discontinued operations, net of tax
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	3	2	-1	-1	0	1	-2	-1	-6	-9	-7	-7	27	28	79	55	96	196	292	393	0	0	0
Earnings from continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,163	343	374	403	335	1,157	1,144	1,105	1,070	1,041	957	908	966	952	927	943	587	595	585	524	758	0	0	0
Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:
Depreciation and amortization
929	966	989	1,000	1,012	1,010	1,048	1,032	971	898	773	717	701	674	677	641	580	537	480	451	451	445	450	459	466	455	426	397	361	345	335	325	312	327	322	313	298	269	256	254	251	235	244	225	0	0	0
Loss on Sale of Investments
1	1	1	3	2	2	2	6	6	7	10	4	0	0	0	-	-	-	-	5	5	37	37	32	0	0	0	-	-	-	-	-	-	-	-	75	73	99	119	45	43	20	-3	0	0	0	0
Impairments and (gain)/loss on disposal of assets, net
-11	-23	-24	488	-863	-846	-905	-1,417	-65	-74	-16	-18	-19	-16	-24	-21	0	0	0	-	-	-	-	-	-	-	-	-859	-29	-25	-21	-21	-36	-7	-8	-9	9	1	3	29	0	0	6	-	-	-	-
Gain (Loss) on Extinguishment of Debt
-	-	-	-	-	-	-	-	-	0	-1	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-40	-39	-39	-39	0	0	0	0
Share-based compensation
86	82	83	82	85	86	87	85	87	89	90	96	102	102	104	111	112	113	115	110	104	101	97	96	97	95	93	93	90	89	89	85	82	79	78	80	81	100	99	100	106	101	110	109	0	0	0
Provision for bad debts
115	95	96	88	83	83	79	74	40	38	45	36	68	67	63	73	61	61	57	52	53	39	42	42	44	51	42	31	33	29	22	22	11	21	25	27	16	13	17	27	39	51	51	51	0	0	0
Change in fair value of contingent consideration obligation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-16	-8	-6	7	8	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in operating assets and liabilities, net of effects from acquisitions and divestitures:
Increase in trade receivables
1,248	439	220	751	395	445	814	871	1,190	1,136	718	665	252	619	824	866	873	972	927	870	1,266	786	761	-925	-1,608	-1,408	-1,682	-216	358	-266	131	129	-431	515	253	457	192	356	-464	-21	96	205	571	713	0	0	0
Increase in inventories
214	789	17	551	691	969	1,008	1,211	528	374	756	673	732	908	982	1,179	1,386	1,207	1,473	779	1,058	895	757	-142	-323	-66	-935	370	-32	-522	541	495	486	617	94	665	190	-3	226	-477	-531	-261	-404	431	0	0	0
Increase in accounts payable
1,466	846	-507	1,864	1,785	1,408	1,837	2,574	1,974	1,108	1,581	564	201	1,947	2,669	2,815	3,130	2,941	2,530	1,948	2,853	2,330	1,499	-196	-1,180	-693	-1,890	426	-679	-768	373	319	581	711	732	1,356	714	714	481	451	856	968	793	768	0	0	0
Other accrued liabilities and operating items, net
-5,309	-5,534	-5,488	-193	-1,034	-1,074	-94	-417	474	834	167	493	448	504	33	147	42	132	-48	-153	-30	-175	29	116	424	362	460	281	105	181	120	129	37	2	167	280	136	137	99	74	51	-46	75	-19	0	0	0
Net cash provided by operating activities-continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,600	1,564	1,943	1,987	2,408	2,241	1,704	951	0	0	0
Net cash provided by operating activities-discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1	-0	1	147	-3	-98	280	472	0	0	0
Net cash provided by operating activities
2,226	2,030	1,704	2,722	2,770	2,044	1,952	2,768	2,938	1,986	2,261	1,184	1,101	2,218	3,127	2,971	3,198	2,937	2,427	2,540	2,388	2,550	1,634	2,524	2,108	2,277	2,110	1,727	1,320	1,224	1,240	1,176	1,403	1,424	1,682	1,395	1,598	1,564	1,945	2,134	2,404	2,143	1,985	1,423	0	0	0
Cash flows from investing activities:
Acquisition of subsidiaries, net of cash acquired
-	-	-	-	-	-	-	6,142	6,161	6,262	6,262	132	344	341	2,224	3,614	3,567	3,701	1,841	503	670	555	555	519	188	2,163	2,164	2,239	2,250	293	267	174	148	12	1,747	2,300	2,307	2,295	559	32	129	154	154	128	0	0	0
Additions to property and equipment
375	361	342	328	330	332	375	384	340	342	354	387	474	503	482	465	445	392	347	300	250	242	259	249	230	223	195	195	205	221	241	260	265	268	274	291	301	303	284	260	371	370	400	421	0	0	0
Purchase of investments
25	14	17	18	13	13	10	9	13	75	145	194	238	237	226	200	358	323	293	342	236	236	204	129	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from return of investments
6	3	4	3	3	2	2	65	178	221	258	228	152	151	145	136	176	156	140	206	129	154	138	47	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from Sale of Property, Plant, and Equipment
-	-	0	-	-	-	0	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0
Proceeds from maturities of available-for-sale securities
-	-	-	-	-	-	-	-	-	-	-	77	62	70	62	50	50	40	42	37	0	0	0	-	-	-	-	71	117	128	105	92	56	45	20	10	0	0	0	-	-	-	-	-	-	-	-
Proceeds from sale of CareFusion common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	706	841	976	271	0	0	0	-	-	-	-
Net cash provided by/(used in) investing activities-continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,743	285	137	-100	-261	-414	-413	0	0	0
Net cash used in investing activities-discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0	-0	-10	-67	-87	-107	-129	0	0	0
Net cash provided by/(used in) investing activities
-422	-408	-414	338	371	1,236	1,215	-5,608	-5,444	-6,417	-6,439	-405	-828	-846	-2,712	-4,080	-4,144	-4,220	-2,246	-849	-950	-810	-880	-850	-404	-2,398	-2,323	-2,375	-2,368	-410	-438	-377	-366	-258	-2,154	-2,028	-1,906	-1,743	285	127	-168	-349	-522	-542	0	0	0
Cash flows from financing activities:
Payment of contingent consideration obligation
-	-	-	-	-	-	-	-	-	-	0	-	-	-	2	25	27	30	30	7	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Net change in short-term borrowings
-2	681	-2	0	0	-205	-44	-50	-72	125	-28	3	17	20	15	26	31	45	-16	-12	40	23	134	114	75	55	29	-1	-6	26	8	13	12	50	41	46	0	0	0	-	-	-	-	-	-	0	0
Purchase of noncontrolling interests
-	-	-	-	-	-	-	106	106	106	5	12	12	22	20	10	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Reduction of long-term obligations
1,988	1,893	1,175	1,102	553	553	553	954	653	653	711	310	61	62	3	6	5	5	1,225	1,221	0	0	0	-	-	-	-	305	0	0	0	-	-	-	-	229	228	10	352	1,486	1,479	1,481	1,285	301	0	0	0
Proceeds from interest rate swap terminations
-	-	-	-	-	-	-	-	-	-	-	-14	-14	-14	-14	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from long-term obligations, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0
Net proceeds/(tax withholdings) from share-based compensation
-5	-12	-14	-14	-13	0	2	-3	3	10	17	26	29	13	18	6	10	30	26	72	67	123	177	227	277	234	175	121	82	57	45	42	50	63	72	63	51	23	18	40	25	46	51	39	0	0	0
Excess Tax Benefit from Share-based Compensation, Financing Activities
-	-	-	-	-	-	-	-	-	-	-	34	37	33	32	33	29	42	45	52	59	42	65	39	0	0	0	-	-	-	-	-	-	-	-	-14	-9	-12	-23	-16	-17	-11	-12	-2	0	0	0
Payment of premiums for debt extinguishment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	66	66	66	66	0	0	0	0
Net tax disbursements from share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	0	-	-	-	-	-	-	-	0	-	-	-	-
Excess tax benefit from exercises of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Dividends on common shares
570	571	573	577	580	578	581	581	578	580	578	577	561	546	530	512	500	486	472	460	449	440	429	415	407	396	374	353	332	313	307	300	294	288	280	274	268	263	259	253	240	227	214	200	0	0	0
Payments for Repurchase of Common Stock
350	350	350	600	700	1,000	1,000	550	450	150	500	600	0	0	0	-	-	-	-	1,036	970	1,309	983	673	639	300	300	450	350	350	350	450	300	300	300	270	449	449	499	230	0	0	0	-	-	-	-
Treasury Stock, Value, Acquired, Cost Method
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in financing activities-continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-219	-1,102	-2,011	-1,853	-1,913	-1,548	-465	0	0	0
Net cash provided by financing activities-discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	1,284	1,283	1,283	1,282	-2	0	0	0
Net cash used in financing activities
-2,915	-2,145	-2,114	-2,293	-1,859	-2,354	-2,296	-2,276	3,293	3,802	3,352	3,746	-1,493	-1,803	-1,377	-1,139	368	736	324	60	-1,296	-1,600	-1,038	-710	-968	607	526	275	944	-356	-372	-454	-589	-716	-229	-193	-369	-218	-1,102	-727	-569	-629	-265	-468	0	0	0
Effect of exchange rates changes on cash and equivalents
2	0	-9	1	-15	-7	-3	4	20	15	6	-2	-10	-12	-11	-12	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase/(decrease) in cash and equivalents
-1,109	-523	-833	768	1,263	933	864	-5,116	807	-632	-820	4,523	-1,230	-443	-973	-2,260	-585	-557	505	1,751	142	140	-284	964	736	486	313	-373	-104	458	430	345	447	449	-701	-826	-676	-398	1,127	1,534	1,667	1,164	1,197	412	0	0	0
Supplemental Information:
Retained investment in CareFusion at date of Spin-Off
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	863	0	0	0	-	-	-	-
Non-cash dividend in connection with Spin-Off
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,689	3,703	3,688	3,688	0	0	0	0
Non-cash investing and financing transactions for:
Investment in CareFusion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0